ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 47 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $410,000 | +1.2% | 50,000 | -50.0% | 0.11% | -53.3% |
| Q4 2016 | $405,000 | -80.9% | 100,000 | -66.7% | 0.24% | -35.8% |
| Q3 2016 | $2,116,000 | +29.8% | 300,000 | +50.0% | 0.38% | -43.1% |
| Q2 2016 | $1,630,000 | -19.8% | 200,000 | -20.0% | 0.66% | -11.0% |
| Q1 2016 | $2,033,000 | -52.3% | 250,000 | -29.2% | 0.74% | -46.8% |
| Q4 2015 | $4,259,000 | +374.3% | 353,161 | +370.9% | 1.40% | +296.9% |
| Q3 2015 | $898,000 | – | 75,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |